"Medicine on target: Mass spectrometry-based assays for cancer biomarker discovery and treatment"
At the conclusion of this activity, the participant will be able to:
- Explain the fundamental principles of targeted mass spectrometry.
- Understand the role of targeted proteomics in cancer biomarker development.
- Appreciate the advantages and disadvantages of mass spectrometry as a diagnostic tool in the clinical laboratory.
- Sponsor(s)
- Medicine: Pathology
- Speaker(s)
- Stefani Thomas, PhD, Clinical Chemistry Fellow, Johns Hopkins, School of Medicine, Department of Pathology
- Audience
- All ( Open to the public )